Using the mean of all data records per patient (n = 32), both for those who developed HCC and those who did not, the ALT cut-off value calculated was 29 UI/L as the threshold for discriminating patients at risk of developing HCC. This evidence concerns the gene GPT and hepatocellular carcinoma.